In an MCAO model study, 11-keto-β-boswellic acid (KBA) activated the Nrf2 pathway in a concentration-dependent manner, therefore significantly inhibiting the level of ROS derived from astrocytes and reducing the volume of cerebral infarction and alleviating the dysfunction of the brain. The gene discussed is NFE2L2; the disease is cerebral infarction.